Biao Xu

Biao Xu

Auto-generated profile, based on publicly available information

Biao Xu

School of Public Health, Hangzhou Medical College, Hangzhou, Zhejiang, China; School of Medicine, and The First Affiliated Hospital, Huzhou University, Huzhou, Zhejiang, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2024 in Environmental Pollution
Verified
Journal Article
Closed access
LFLingfang Feng
Lingfang Feng
TLTao Li
Tao Li
BXBiao Xu
Biao Xu
JHJing Huang
Jing Huang
HXHailing Xia
Hailing Xia
JLJianlin Lou
Jianlin Lou

1 March 2024 in Toxicology Research
Verified
Journal Article
Closed access
PDF file
YQYao Qin
Yao Qin
XHXU Huadong
XU Huadong
YXYongyong Xi
Yongyong Xi
LFLingfang Feng
Lingfang Feng
JCJunfei Chen
Junfei Chen
JLJianlin Lou
Jianlin Lou
Our previous study identified the potential of SEMA4B methylation level as a biomarker for hexavalent chromium [Cr(VI)] exposure. This study aimed to investigate the role of the SEMA4B gene in Cr(VI)-mediated malignant transformation of human bronchial epithelial (BEAS-2B) cells. In our population survey of workers, the geometric mean [95% confidence intervals (CIs)] of Cr in blood was 3.80 (0.42, 26.56) μg/L. Following treatment with various doses of Cr(VI), it was found that 0.5 μM had negligible effects on the cell viability of BEAS-2B cells. The expression of SEMA4B was observed to decrease in BEAS-2B cells after 7 days of treatment with 0.5 μM Cr(VI), and this downregulation continued with increasing passages of Cr(VI) treatment. Chronic exposure to 0.5 μM Cr(VI) enhanced the anchorage-independent growth ability of BEAS-2B cells. Furthermore, the use of a methylation inhibitor suppressed the Cr(VI)-mediated anchorage-independent growth in BEAS-2B cells. Considering that Cr levels exceeding 0.5 μM can be found in human blood due to occupational exposure, the results suggested a potential carcinogenic risk associated with occupational Cr(VI) exposure through the promotion of malignant transformation. The in vitro study further demonstrated that Cr(VI) exposure might inhibit the expression of the SEMA4B gene to promote the malignant transformation of BEAS-2B cells.